Importantly, Gao et al. observed that AT-I could inhibit MPTP/MPP+-mediated oxidative stress and ROS production in neuroblastoma cells by activating Nrf2, alleviating motor deficits in mice with Parkinson’s disease [55]. This evidence concerns the gene NFE2L2 and Parkinson disease.